Semi-Annual Consolidated Statement Of Income

STELLA PHARMA CORPORATION - Filing #7299803

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Semi-annual consolidated statement of income
Statement of income
Net sales
169,394,000 JPY
153,995,000 JPY
Cost of sales
22,182,000 JPY
30,922,000 JPY
Ordinary profit (loss)
-267,279,000 JPY
-303,679,000 JPY
Gross profit (loss)
147,211,000 JPY
123,072,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
416,291,000 JPY
424,305,000 JPY
Extraordinary losses
JPY
750,000 JPY
Profit (loss) before income taxes
-267,279,000 JPY
-304,430,000 JPY
Operating profit (loss)
-269,080,000 JPY
-301,233,000 JPY
Non-operating income
Interest income
696,000 JPY
724,000 JPY
Non-operating income
7,429,000 JPY
857,000 JPY
Income taxes - current
1,441,000 JPY
1,425,000 JPY
Non-operating expenses
Interest expenses
1,683,000 JPY
1,061,000 JPY
Non-operating expenses
5,628,000 JPY
3,303,000 JPY
Income taxes
1,441,000 JPY
1,425,000 JPY
Profit (loss)
-268,720,000 JPY
-305,856,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.